-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Letter: NEURON – a network of European funding organizations ||FREE PAPER||
(2024) Views (418) Full article downloads
Authors: Marlies Dorlöchter and Hella Lichtenberg
Published Date May 2005
Volume 2005:1(1) Pages 87 - 88
DOI: http://dx.doi.org/10.2147/NDT.S
Marlies Dorlöchter and Hella Lichtenberg
Project Management Organisation, German Aerospace Center, Bonn, Germany; email Marlies Dorlöchter marlies.dorloechter@dlr.de
There is little doubt that the maintenance and restoration of health are highly valued and fundamental to citizens in all countries. Among the many diseases affecting health, brain disorders are major causes for impaired quality of life. According to estimates by the World Health Organization, more than one billion people suffer from disorders of the central nervous system (WHO 2001). In Europe, approximately one-third of all burden of disease is caused by brain diseases (Olesen and Leonardi 2003). With increasing average life-expectancy, especially in highly industrialized countries, and the rapidly growing incidence of neurodegenerative diseases, this percentage will rise even further. Neuroscience research and its translation into diagnostic and therapeutic measures is therefore a high priority.
Readers of this article also read:
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
On prediction of optical properties of two- and multiphase nanocomposites for nanomedicine
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
Editorial Foreword || FREE PAPER ||
Letter - Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disoder patients
Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Moderate alcohol consumption and cognitive risk
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
